West Pharmaceutical Services Management
Management Kriterienprüfungen 4/4
West Pharmaceutical Services' CEO ist Eric Green , ernannt in Apr 2015, hat eine Amtszeit von 9.17 Jahren. Die jährliche Gesamtvergütung beträgt $9.40M , bestehend aus 12.1% Gehalt und 87.9% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.22% der Aktien des Unternehmens, im Wert von $54.41M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 4.6 Jahre bzw. 9.1 Jahre.
Wichtige Informationen
Eric Green
Geschäftsführender
US$9.4m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 12.1% |
| Amtszeit als Geschäftsführer | 9.2yrs |
| Eigentum des Geschäftsführers | 0.2% |
| Durchschnittliche Amtszeit des Managements | 4.6yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 9.1yrs |
Jüngste Management Updates
Recent updates
We Think West Pharmaceutical Services (NYSE:WST) Can Stay On Top Of Its Debt
Jun 27
Estimating The Fair Value Of West Pharmaceutical Services, Inc. (NYSE:WST)
May 21West Pharmaceutical: Pick And Shovels Of The Injectable Drug Industry
May 11West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Yet to Catch Up With Its Share Price
Mar 30Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?
Mar 12Why West Pharma Is Far From Done
Feb 28West Pharmaceutical Services, Inc.'s (NYSE:WST) Intrinsic Value Is Potentially 19% Below Its Share Price
Feb 20West Pharmaceutical Services: Still Too Expensive After The Recent Drop
Feb 20What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?
Jan 10West Pharmaceutical: Great Business, Not So Great Valuation
Jan 08What West Pharmaceutical Services, Inc.'s (NYSE:WST) P/E Is Not Telling You
Dec 18West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet
Nov 27West Pharmaceutical Services: The Run Might Be Over
Oct 18Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?
Sep 24Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
Aug 22West Pharmaceutical: Revise To Buy On Exceptional Economic Characteristics
Aug 08What Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Doing?
Jun 26West Pharmaceutical: Hard To Justify The Price
May 26Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
May 16At US$330, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?
Mar 20West Pharmaceutical Services' (NYSE:WST) Soft Earnings Don't Show The Whole Picture
Feb 28West Pharmaceutical Q4 2022 Earnings Preview
Feb 15West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet
Jan 31West Pharmaceutical: An Earnings Decline Seen In 2023, Shares Still Appear Expensive
Dec 19West Pharmaceutical declares $0.19 dividend
Dec 13Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching
Nov 29West Pharmaceutical Q3 2022 Earnings Preview
Oct 26West Pharmaceutical Services (NYSE:WST) Seems To Use Debt Rather Sparingly
Oct 25West Pharmaceutical Services: Shares Need To Get Cheaper To Make Sense
Oct 02Is West Pharmaceutical Services, Inc. (NYSE:WST) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 14Is There Now An Opportunity In West Pharmaceutical Services, Inc. (NYSE:WST)?
Aug 31Do West Pharmaceutical Services' (NYSE:WST) Earnings Warrant Your Attention?
Aug 18West Pharmaceutical Q2 Non-GAAP EPS, revenue beats
Jul 28Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
Jul 27West Pharmaceutical Services: A Great Business At A Lofty Price
Jul 06Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$569m |
| Dec 31 2023 | US$9m | US$1m | US$593m |
| Sep 30 2023 | n/a | n/a | US$559m |
| Jun 30 2023 | n/a | n/a | US$519m |
| Mar 31 2023 | n/a | n/a | US$552m |
| Dec 31 2022 | US$8m | US$1m | US$586m |
| Sep 30 2022 | n/a | n/a | US$631m |
| Jun 30 2022 | n/a | n/a | US$686m |
| Mar 31 2022 | n/a | n/a | US$684m |
| Dec 31 2021 | US$9m | US$1m | US$662m |
| Sep 30 2021 | n/a | n/a | US$613m |
| Jun 30 2021 | n/a | n/a | US$519m |
| Mar 31 2021 | n/a | n/a | US$423m |
| Dec 31 2020 | US$8m | US$989k | US$346m |
| Sep 30 2020 | n/a | n/a | US$312m |
| Jun 30 2020 | n/a | n/a | US$286m |
| Mar 31 2020 | n/a | n/a | US$261m |
| Dec 31 2019 | US$7m | US$936k | US$242m |
| Sep 30 2019 | n/a | n/a | US$230m |
| Jun 30 2019 | n/a | n/a | US$229m |
| Mar 31 2019 | n/a | n/a | US$219m |
| Dec 31 2018 | US$5m | US$880k | US$207m |
| Sep 30 2018 | n/a | n/a | US$155m |
| Jun 30 2018 | n/a | n/a | US$151m |
| Mar 31 2018 | n/a | n/a | US$133m |
| Dec 31 2017 | US$5m | US$824k | US$151m |
Vergütung im Vergleich zum Markt: EricDie Gesamtvergütung ($USD9.40M) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD13.53M).
Entschädigung vs. Einkommen: EricDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.
Geschäftsführer
Eric Green (54 yo)
9.2yrs
Amtszeit
US$9,395,896
Vergütung
Mr. Eric M. Green serves as Independent Director at Ecolab Inc. since December 08, 2022. He has been the Chief Executive Officer of West Pharmaceutical Services, Inc. since April 24, 2015 and its President...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Non-Independent Chair of the Board | 9.2yrs | US$9.40m | 0.22% $ 53.3m | |
| Senior VP & CFO | 6yrs | US$3.64m | 0.0095% $ 2.3m | |
| Senior VP & CTO | 3.5yrs | US$1.67m | 0.0039% $ 943.0k | |
| Senior VP | 3.5yrs | US$1.49m | 0.0019% $ 448.7k | |
| Senior VP & Chief Commercial Officer | 4.6yrs | US$1.53m | 0.0067% $ 1.6m | |
| VP, Chief Accounting Officer & Corporate Controller | 4.7yrs | keine Daten | 0.0018% $ 431.9k | |
| Vice President of Investor Relations | 8.4yrs | keine Daten | 0.026% $ 6.2m | |
| Vice President of Global Communications | no data | keine Daten | keine Daten | |
| Senior VP of Strategy & Corporate Development | less than a year | keine Daten | keine Daten | |
| Chief Human Resources Officer & Senior VP | 8.7yrs | US$1.14m | 0.0089% $ 2.1m | |
| Senior Vice President of Integrated Systems | 4.6yrs | keine Daten | keine Daten | |
| Senior VP and Chief Quality & Regulatory Officer | 2.1yrs | keine Daten | keine Daten |
4.6yrs
Durchschnittliche Betriebszugehörigkeit
55yo
Durchschnittliches Alter
Erfahrenes Management: WSTDas Führungsteam des Unternehmens gilt als erfahren (4.6 Jahre durchschnittliche Betriebszugehörigkeit).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Non-Independent Chair of the Board | 9.1yrs | US$9.40m | 0.22% $ 53.3m | |
| Independent Director | 10.3yrs | US$359.35k | 0.024% $ 5.7m | |
| Independent Director | 4.3yrs | US$330.66k | 0.0033% $ 801.4k | |
| Independent Director | 16.7yrs | US$390.35k | 0.059% $ 14.2m | |
| Independent Director | 13.3yrs | US$378.23k | 0.056% $ 13.4m | |
| Independent Director | 13.3yrs | US$377.01k | 0.059% $ 14.1m | |
| Lead Independent Director | 7.8yrs | US$367.44k | 0.012% $ 2.9m | |
| Independent Director | 1.9yrs | US$331.46k | 0.0015% $ 352.7k | |
| Independent Director | 12.3yrs | US$362.83k | 0.040% $ 9.6m | |
| Independent Director | 7yrs | US$333.45k | keine Daten | |
| Honorary Director | no data | keine Daten | keine Daten | |
| Independent Director | 2.8yrs | US$321.43k | 0.00087% $ 208.7k |
9.1yrs
Durchschnittliche Betriebszugehörigkeit
63yo
Durchschnittliches Alter
Erfahrener Vorstand: WSTDie Vorstandsmitglieder gelten als erfahren (9.1 Jahre durchschnittliche Amtszeit).